Good. If we take these ideas and expand them into the rare disease area, where you're talking about a very small population, what kind of a model are you recommending then to actually produce the drugs? Is it like a Breaking Bad lab that does rare diseases, or what are we talking about?
On October 16th, 2018. See this statement in context.